Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout

ClinicalTrials.gov ID: NCT03994731

Public ClinicalTrials.gov record NCT03994731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving KRYSTEXXA® (Pegloticase) (MIRROR Randomized Controlled Trial [RCT])

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the potential for pegloticase with methotrexate (MTX) to increase the response rate seen with pegloticase alone, and to characterize the safety, tolerability and pharmacokinetics (PK) of the concomitant use of pegloticase with MTX, by comparing pegloticase co-administered with MTX to pegloticase co-administered with placebo for MTX in adults with uncontrolled gout.

Study identification

NCT ID
NCT03994731
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
152 participants

Conditions and interventions

Conditions

Interventions

Biological · Drug · Dietary Supplement

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 13, 2019 (Actual)
Primary completion
Mar 17, 2021 (Actual)
Completion
Apr 11, 2022 (Actual)
Last update posted
Jun 26, 2024

2019 – 2022

United States locations

U.S. sites
60
U.S. states
22
U.S. cities
57
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35294 —
Orthopedic Physicians Alaska Anchorage Alaska 99508 —
Arizona Arthritis and Rheumatology Research, PLLC - Flagstaff Flagstaff Arizona 86001 —
Arizona Arthritis and Rheumatology Research, PLLC-West Glendale Arizona 85306 —
Arizona Arthritis and Rheumatology Research, PLLC-East Mesa Arizona 85210 —
Applied Research Center of Arkansas, Inc Little Rock Arkansas 72212 —
TriWest Research Associates El Cajon California 92020 —
Advanced Investigative Medicine, Inc. Hawthorne California 90250 —
Axis Clinical Trials Los Angeles California 90036 —
ACRC Studies Poway California 92064 —
ClinEdge Sierra Rheumatology, Inc. Roseville California 95661 —
East Bay Rheumatology Medical Group, Inc. San Leandro California 94578 —
Providence St. John's Health Clinic Santa Monica California 90404 —
Medvin Clinical Research Tujunga California 91042 —
San Fernando Valley Health Institute Van Nuys California 91405 —
Ventura Clinical Trials Ventura California 93003 —
University of Colorado Division of Rheumatology Aurora Colorado 80045 —
Denver Arthritis Clinic Denver Colorado 80230 —
Avail Clinical Research DeLand Florida 32720 —
Prohealth Research Center Doral Florida 33166 —
Omega Research Maitland Orlando Florida 32808 —
DMI Research Pinellas Park Florida 33782 —
Napa Research Center Pompano Beach Florida 33064 —
GCP Clinical Research Tampa Florida 33609 —
Florida Medical Clinic, LLC Zephyrhills Florida 33542 —
St. Luke's Clinic - Rheumatology Meridian Idaho 83642 —
MD Medical Research Oxon Hill Maryland 20745 —
The Center for Rheumatology and Bone Research Wheaton Maryland 20902 —
Infusion Associates Grand Rapids Michigan 49525 —
Clinical Research Institute of Michigan, LLC Saint Clair Shores Michigan 48081 —
Benefis Hospital Great Falls Montana 59405 —
Physician Research Collaboration, LLC Lincoln Nebraska 68516 —
Santa Fe Rheumatology Santa Fe New Mexico 87505 —
Long Island Arthritis & Osteoporosis Care Babylon New York 11702 —
Buffalo Rheumatology and Medicine Orchard Park New York 14127 —
NorthEast Rheumatology/Atrium Health Concord North Carolina 28025 —
NorthEast Rheumatology Concord North Carolina 28025 —
Medication Management, LLC Greensboro North Carolina 27408 —
ClinEdge PMG Research of Hickory, LLC Hickory North Carolina 28602 —
ClinEdge PMG Research of Salisbury, LLC Salisbury North Carolina 28144 —
Shelby Clinical Research, LLC Shelby North Carolina 28150 —
PMG Research of Wilmington, LLC Wilmington North Carolina 28401 —
Premier Clinical/STAT Research Dayton Ohio 45417 —
Paramount Medical Research & Consulting, LLC Middleburg Heights Ohio 44130 —
Clinical Research Source Inc. Perrysburg Ohio 43551 —
Premier Clinical/STAT Research - Springboro Springboro Ohio 45066 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Piedmont Arthritis Clinic Greenville South Carolina 29601 —
Articularis Healthcare Group Summerville South Carolina 29486 —
West Tennessee Research Institute Jackson Tennessee 38305 —
Ramesh C. Gupta, M.D. Memphis Tennessee 38119 —
Diagnostic and Interventional Nephrology Of Houston Houston Texas 77004 —
Research Consultants - Frostwood Houston Texas 77024 —
Research Consultants - Astoria Houston Texas 77089 —
Arthritis Clinic of Central Texas San Marcos Texas 78666 —
Arthritis & Osteoporosis Clinic - Waco Waco Texas 76710 —
Clear Lake Specialties Webster Texas 77598 —
Western Washington Arthritis Clinic Bothell Washington 98021 —
Arthritis Northwest Spokane Washington 99204 —
Rheumatic Disease Center Glendale Wisconsin 53219 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03994731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03994731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →